A Texas judge has permitted Idaho, Kansas, and Missouri to proceed with a lawsuit aimed at restricting access to mifepristone, a commonly used abortion drug. The ruling from Judge Matthew Kacsmaryk, a Trump nominee, comes after former attempts to challenge federal regulations failed in the Supreme Court. The involved states seek to tighten FDA policies, demanding restrictions on telehealth prescriptions and limiting use to early weeks of pregnancy. Critics argue such actions undermine federal rules and women's health rights, while supporters claim they are necessary to uphold state abortion laws.